Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and mycophenolic acid

levofloxacin has been researched along with mycophenolic acid in 7 studies

Compound Research Comparison

Studies
(levofloxacin)		Trials
(levofloxacin)		Recent Studies (post-2010)
(levofloxacin)		Studies
(mycophenolic acid)		Trials
(mycophenolic acid)		Recent Studies (post-2010) (mycophenolic acid)
4,3465812,2099,0291,5063,772

Protein Interaction Comparison

ProteinTaxonomylevofloxacin (IC50)mycophenolic acid (IC50)
Inosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)0.1496
Glutamate receptor 1Rattus norvegicus (Norway rat)0.014
Glutamate receptor 2Rattus norvegicus (Norway rat)0.014
Glutamate receptor 3Rattus norvegicus (Norway rat)0.014
Glutamate receptor 4Rattus norvegicus (Norway rat)0.014
Inosine-5'-monophosphate dehydrogenase 1 Homo sapiens (human)0.0772
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.011
Inosine-5'-monophosphate dehydrogenaseCryptococcus neoformans var. neoformans JEC210.12

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Andricopulo, AD; Moda, TL; Montanari, CA1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Farney, AC; Mendley, SR; Mian, AN1
Homma, M; Ohkohchi, N; Watanabe, M; Yuzawa, K1
Kodawara, T; Masada, M; Masuda, S; Matsubara, K; Nakamura, T; Yano, Y1

Reviews

1 review(s) available for levofloxacin and mycophenolic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for levofloxacin and mycophenolic acid

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:1

    Topics: Adolescent; Arthritis, Infectious; Doxycycline; Edema; Female; Graft Survival; Hip; Humans; Immunocompromised Host; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Levofloxacin; Magnetic Resonance Imaging; Mycophenolic Acid; Mycoplasma hominis; Ofloxacin; Pelvis; Prednisone; Radiography; Tacrolimus; Treatment Outcome

2005
Establishment of an animal model with side effects induced by mycophenolate mofetil and pharmacohistological analysis of them.
    Transplantation proceedings, 2006, Volume: 38, Issue:10

    Topics: Animals; Body Weight; Diarrhea; Energy Intake; Feeding Behavior; Immunosuppressive Agents; Levofloxacin; Male; Mice; Mice, Inbred BALB C; Models, Animal; Mycophenolic Acid; Ofloxacin; Weight Loss

2006
Inhibitory effect of ciprofloxacin on β-glucuronidase-mediated deconjugation of mycophenolic acid glucuronide.
    Biopharmaceutics & drug disposition, 2014, Volume: 35, Issue:5

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Enterohepatic Circulation; Glucuronidase; Glucuronides; Immunosuppressive Agents; In Vitro Techniques; Inhibitory Concentration 50; Levofloxacin; Mycophenolic Acid; Ofloxacin; Phenolphthaleins; Time Factors

2014